308 related articles for article (PubMed ID: 28556672)
1. Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study.
Yale JF; Dulude H; Egeth M; Piché CA; Lafontaine M; Carballo D; Margolies R; Dissinger E; Shames AR; Kaplowitz N; Zhang MX; Zhang S; Guzman CB
Diabetes Technol Ther; 2017 Jul; 19(7):423-432. PubMed ID: 28556672
[TBL] [Abstract][Full Text] [Related]
2. NASAL GLUCAGON DELIVERY IS MORE SUCCESSFUL THAN INJECTABLE DELIVERY: A SIMULATED SEVERE HYPOGLYCEMIA RESCUE.
Settles JA; Gerety GF; Spaepen E; Suico JG; Child CJ
Endocr Pract; 2020 Apr; 26(4):407-415. PubMed ID: 32293921
[No Abstract] [Full Text] [Related]
3. Perceptions About Glucagon Delivery Devices for Severe Hypoglycemia: Qualitative Research With Patients, Caregivers, and Acquaintances.
Bajpai SK; Cambron-Mellott MJ; Peck E; Poon JL; Wang Q; Mitchell BD; Babrowicz J; Child CJ; Raibulet NK; Beusterien K
Clin Ther; 2019 Oct; 41(10):2073-2089.e6. PubMed ID: 31526655
[TBL] [Abstract][Full Text] [Related]
4. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
Deeb LC; Dulude H; Guzman CB; Zhang S; Reiner BJ; Piché CA; Pradhan S; Zhang XM
Pediatr Diabetes; 2018 Aug; 19(5):1007-1013. PubMed ID: 29512902
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
[TBL] [Abstract][Full Text] [Related]
6. Nasal Glucagon Is Easier to Use and More Preferred and Needs Less Effort to Administer Than Injectable Glucagon: User Perceptions of Glucagon Administration During Severe Hypoglycemia Simulation.
Settles J; Hinnen D; Spaepen E; Bajpai S; Turakhiya A; Ghodke S; Child CJ
Endocr Pract; 2022 May; 28(5):486-493. PubMed ID: 35263661
[TBL] [Abstract][Full Text] [Related]
7. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
Pontiroli AE; Ceriani V
Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
[TBL] [Abstract][Full Text] [Related]
8. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.
Pontiroli AE; Tagliabue E
Acta Diabetol; 2020 Jun; 57(6):743-749. PubMed ID: 32025860
[TBL] [Abstract][Full Text] [Related]
9. Needle-free nasal delivery of glucagon for treatment of diabetes-related severe hypoglycemia: toxicology of polypropylene resin used in delivery device.
Reno FE; Edwards CN; Bendix Jensen M; Török-Bathó M; Esdaile DJ; Piché C; Triest M; Carballo D
Cutan Ocul Toxicol; 2016 Sep; 35(3):242-7. PubMed ID: 26426957
[TBL] [Abstract][Full Text] [Related]
10. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis.
Pöhlmann J; Mitchell BD; Bajpai S; Osumili B; Valentine WJ
J Diabetes Sci Technol; 2019 Sep; 13(5):910-918. PubMed ID: 30700165
[TBL] [Abstract][Full Text] [Related]
11. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
Haymond MW; Schreiner B
Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies.
Lowe RN; Trujillo JM
Ann Pharmacother; 2020 Aug; 54(8):780-787. PubMed ID: 32052651
[No Abstract] [Full Text] [Related]
13. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting.
Seaquist ER; Dulude H; Zhang XM; Rabasa-Lhoret R; Tsoukas GM; Conway JR; Weisnagel SJ; Gerety G; Woo VC; Zhang S; Carballo D; Pradhan S; Piché CA; Guzman CB
Diabetes Obes Metab; 2018 May; 20(5):1316-1320. PubMed ID: 29504662
[TBL] [Abstract][Full Text] [Related]
14. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions.
La Sala L; Pontiroli AE
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638984
[TBL] [Abstract][Full Text] [Related]
15. People With Diabetes and Caregivers Prefer Rescue Glucagon Treatment With a Wider Storage Temperature Range and a Nasal Administration, When Efficacy is Similar: A Discrete Choice Experiment in Spain.
Mitchell BD; Rentz AM; Kummer S; Yan Y; Heidenreich S; Krucien N; Artime E; Osumili B; Rubio M; Gelhorn HL
J Diabetes Sci Technol; 2023 Nov; 17(6):1623-1633. PubMed ID: 35533142
[TBL] [Abstract][Full Text] [Related]
16. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cost and medical resource use outcomes associated with nasal glucagon versus injectable glucagon for treatment of severe hypoglycemia in people with diabetes in Canada: a modeling analysis.
Yale JF; Osumili B; Mitchell BD; Hunt B; Sohi G; Jeddi M; Mojdami D; Valentine WJ
J Med Econ; 2022; 25(1):238-248. PubMed ID: 35094622
[TBL] [Abstract][Full Text] [Related]
18. A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia.
Bailey NC; Dimsits J; Hammer M; Kendall DM; Bailey TS
Diabetes Technol Ther; 2022 Apr; 24(4):231-240. PubMed ID: 34809479
[No Abstract] [Full Text] [Related]
19. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
Pontiroli AE
J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
[TBL] [Abstract][Full Text] [Related]
20. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
Stenninger E; Aman J
Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
